← Filings of DOC
Tables in the 10-Q of HEALTHPEAK PROPERTIES, INC.
57 tables with numbers, filed Nov 3, 2026. Each one downloads as a CSV for Excel or
Google Sheets, with the filing's address in the last row. Only the layout is tidied (a "$" or ")" in a cell of its own is joined to its number); no value is changed.
Open the filing on sec.gov ↗
| PART I. FINANCIAL INFORMATION | | |
| Item 1. | Financial Statements (Unaudited): | 3 |
| Consolidated Balance Sheets | 3 |
| Consolidated Statements of Operations | 4 |
| Consolidated Statements of Comprehensive Income (Loss) | 5 |
| Consolidated Statements of Equity and Redeemable Noncontrolling Interests | 6 |
| Consolidated Statements of Cash Flows | 8 |
| Notes to the Consolidated Financial Statements | 9 |
First 8 of 17 rows. The CSV has all of them.
| September 30, 2026 | December 31, 2025 | |
| ASSETS | | | |
| Real estate: | | | |
| Buildings and improvements | $18,744,157 | | $16,593,535 |
| Development costs and construction in progress | 1,026,355 | | 1,010,657 |
| Land and improvements | 3,426,289 | | 3,007,346 |
| Accumulated depreciation | (4,708,201) | | (4,512,443) |
| Net real estate | 18,488,600 | | 16,099,095 |
First 8 of 44 rows. The CSV has all of them.
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Revenues: | | | | | | |
| Rental and related revenues | $545,390 | | $539,886 | | $1,617,180 | $1,607,714 |
| Resident fees and services | 268,300 | | 150,458 | | 685,101 | 448,240 |
| Interest income and other | 7,202 | | 15,529 | | 43,142 | 47,156 |
| Total revenues | 820,892 | | 705,873 | | 2,345,423 | 2,103,110 |
| Costs and expenses: | | | | | | |
First 8 of 34 rows. The CSV has all of them.
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Net income (loss) | $36,687 | | $(109,848) | | $299,584 | $(20,765) |
| Other comprehensive income (loss): | | | | | | |
| Net unrealized gains (losses) on derivatives | 17,450 | | (3,027) | | 37,774 | (37,005) |
| Change in Supplemental Executive Retirement Plan obligation and other | 74 | | 71 | | 221 | 212 |
| Total other comprehensive income (loss) | 17,524 | | (2,956) | | 37,995 | (36,793) |
| Total comprehensive income (loss) | 54,211 | | (112,804) | | 337,579 | (57,558) |
First 8 of 10 rows. The CSV has all of them.
Table 5 after “For the three months ended September 30, 2026:”
Download CSV
| Common Stock | Additional Paid-In Capital | | Cumulative Dividends In Excess Of Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | | Total Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | | | | |
| Shares | Amount | | | | | | | | | | | | |
| July 1, 2026 | 689,465 | | $689,465 | | $13,273,880 | | $(6,129,129) | | $10,534 | | $7,844,750 | $1,625,995 | $9,470,745 | $27,695 |
| Net income (loss) | — | | — | | — | | 17,263 | | — | | 17,263 | 19,501 | 36,764 | (77) |
| Other comprehensive income (loss) | — | | — | | — | | — | | 17,524 | | 17,524 | — | 17,524 | — |
| Issuance of common stock, net | 29 | | 29 | | 219 | | — | | — | | 248 | — | 248 | — |
| Conversion of non-managing member units to common stock | 46 | | 46 | | 1,432 | | — | | — | | 1,478 | (1,478) | — | — |
| Repurchase of common stock | (4) | | (4) | | (101) | | — | | — | | (105) | — | (105) | — |
First 8 of 14 rows. The CSV has all of them.
Table 6 after “For the three months ended September 30, 2025:”
Download CSV
| Common Stock | Additional Paid-In Capital | | Cumulative Dividends In Excess Of Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | | Total Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | | | | |
| Shares | Amount | | | | | | | | | | | | |
| July 1, 2025 | 694,916 | | $694,916 | | $12,763,723 | | $(5,525,520) | | $(5,019) | | $7,928,100 | $638,737 | $8,566,837 | $20,104 |
| Net income (loss) | — | | — | | — | | (117,122) | | — | | (117,122) | 7,381 | (109,741) | (107) |
| Other comprehensive income (loss) | — | | — | | — | | — | | (2,956) | | (2,956) | — | (2,956) | — |
| Issuance of common stock, net | 24 | | 24 | | 359 | | — | | — | | 383 | — | 383 | — |
| Conversion of non-managing member units to common stock | 7 | | 7 | | 191 | | — | | — | | 198 | (198) | — | — |
| Repurchase of common stock | (1) | | (1) | | (16) | | — | | — | | (17) | — | (17) | — |
First 8 of 14 rows. The CSV has all of them.
Table 7 after “For the nine months ended September 30, 2026:”
Download CSV
| Common Stock | Additional Paid-In Capital | | Cumulative Dividends In Excess Of Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | | Total Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | | | | |
| Shares | Amount | | | | | | | | | | | | |
| January 1, 2026 | 695,037 | | $695,037 | | $12,767,914 | | $(5,952,920) | | $(9,937) | | $7,500,094 | $642,776 | $8,142,870 | $159,581 |
| Net income (loss) | — | | — | | — | | 263,714 | | — | | 263,714 | 36,283 | 299,997 | (413) |
| Other comprehensive income (loss) | — | | — | | — | | — | | 37,995 | | 37,995 | — | 37,995 | — |
| Issuance of common stock, net | 419 | | 419 | | 972 | | — | | — | | 1,391 | — | 1,391 | — |
| Conversion of non-managing member units to common stock | 117 | | 117 | | 3,142 | | — | | — | | 3,259 | (3,259) | — | — |
| Repurchase of common stock | (6,037) | | (6,037) | | (95,629) | | — | | — | | (101,666) | — | (101,666) | — |
First 8 of 16 rows. The CSV has all of them.
Table 8 after “For the nine months ended September 30, 2025:”
Download CSV
| Common Stock | Additional Paid-In Capital | | Cumulative Dividends In Excess Of Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | | Total Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | | | | |
| Shares | Amount | | | | | | | | | | | | |
| January 1, 2025 | 699,485 | | $699,485 | | $12,847,252 | | $(5,174,279) | | $28,818 | | $8,401,276 | $653,738 | $9,055,014 | $2,610 |
| Net income (loss) | — | | — | | — | | (42,621) | | — | | (42,621) | 22,145 | (20,476) | (289) |
| Other comprehensive income (loss) | — | | — | | — | | — | | (36,793) | | (36,793) | — | (36,793) | — |
| Issuance of common stock, net | 521 | | 521 | | 415 | | — | | — | | 936 | — | 936 | — |
| Conversion of non-managing member units to common stock | 171 | | 171 | | 3,967 | | — | | — | | 4,138 | (4,138) | — | — |
| Repurchase of common stock | (5,231) | | (5,231) | | (91,827) | | — | | — | | (97,058) | — | (97,058) | — |
First 8 of 14 rows. The CSV has all of them.
| Nine Months Ended September 30, | | |
| 2026 | 2025 | |
| Cash flows from operating activities: | | | |
| Net income (loss) | $299,584 | | $(20,765) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | |
| Depreciation and amortization of real estate, in-place lease, and other intangibles | 872,047 | | 796,779 |
| Stock-based compensation amortization expense | 14,170 | | 10,410 |
| Stock-based compensation issued as part of initial public offering of Janus Living, Inc. | 4,872 | | — |
First 8 of 57 rows. The CSV has all of them.
Table 10 after “The following table summarizes senior housing communities acquired during the nine months ended September 30, 2026, excluding the JV Buyout ”
Download CSV
| Acquisitions Closed During the Three Months Ended | State | Number of Properties | Purchase Price (in millions) |
| March 31, 2026 | | | |
| Georgia | 2 | $240 |
| Florida | 3 | 119 |
| Washington | 1 | 41 |
| June 30, 2026 | | | |
| Washington | 1 | 53 |
| Arizona | 1 | 52 |
First 8 of 20 rows. The CSV has all of them.
Table 11 after “The following table summarizes the Company’s lease income (in thousands):”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Fixed income from operating leases | $389,168 | | $392,915 | | $1,163,333 | $1,178,305 |
| Variable income from operating leases | 156,222 | | 146,971 | | 453,847 | 429,409 |
Table 12 after “The following table summarizes the Company’s loans receivable (in thousands):”
Download CSV
| September 30, 2026 | December 31, 2025 | |
| Secured loans(1) | $240,963 | | $583,460 |
| Mezzanine loans | 52,192 | | 47,690 |
| Unamortized discounts and fees | (916) | | (13,785) |
| Reserve for loan losses | (8,036) | | (11,345) |
| Loans receivable, net | $284,203 | | $606,020 |
Table 13 after “The following is a summary of the Company’s loans receivable activity for the periods presented (in thousands):”
Download CSV
| Secured Loans | Mezzanine Loans | |
| Loans receivable as of December 31, 2024 | $638,482 | | $50,314 |
| Add: Advances on and acquisitions of loans receivable | 87,648 | | 4,756 |
| Less: Receipts on loans receivable and other reductions(1) | (142,670) | | (7,380) |
| Loans receivable as of December 31, 2025 | 583,460 | | 47,690 |
| Add: Advances on and acquisitions of loans receivable | 56,502 | | 9,342 |
| Less: Receipts on loans receivable and other reductions | (398,999) | | (4,840) |
| Loans receivable as of September 30, 2026 | $240,963 | | $52,192 |
Table 14 after “The following table summarizes, by year of origination, the Company’s internal ratings for loans receivable, net of unamortized discounts, f”
Download CSV
| Investment Type | | Year of Origination(1) | | Total | | | | | | | | |
| 2026 | | 2025 | | 2024 | 2023 | | 2022 | Prior | | | |
| Secured loans | | | | | | | | | | | | |
| Risk rating: | | | | | | | | | | | | |
| Performing loans | | $10,540 | | | $67,324 | | $80,605 | | $42,756 | $34,319 | $— | $235,544 |
| Watch list loans | | — | | | — | | — | | — | — | — | — |
| Workout loans | | — | | | — | | — | | — | — | — | — |
| Total secured loans | | $10,540 | | | $67,324 | | $80,605 | | $42,756 | $34,319 | $— | $235,544 |
First 8 of 20 rows. The CSV has all of them.
Table 15 after “The following table summarizes the Company’s reserve for loan losses (in thousands):”
Download CSV
| September 30, 2026 | December 31, 2025 | | | | | | | |
| Secured Loans | Mezzanine Loans | | Total | Secured Loans | Mezzanine Loans | | Total | |
| Reserve for loan losses, beginning of period | $4,750 | | $6,595 | | $11,345 | | $5,574 | $4,925 | $10,499 |
| Provision for expected loan losses on funded loans receivable | 83 | | (3,228) | | (3,145) | | 908 | 2,215 | 3,123 |
| Expected loan losses (recoveries) related to loans sold or repaid in full | — | | (164) | | (164) | | (1,732) | (545) | (2,277) |
| Reserve for loan losses, end of period | $4,833 | | $3,203 | | $8,036 | | $4,750 | $6,595 | $11,345 |
Table 16 after “The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):”
Download CSV
| | | | Carrying Amount | | | |
| | | | | September 30, | December 31, | |
| Entity(1) | Segment | Property Count(2) | Ownership %(2) | | 2026 | 2025 | |
| South San Francisco JVs(3) | Lab | 7 | 70 | | $285,388 | | $285,387 |
| Callan Ridge JV | Lab | 2 | 35 | | 73,456 | | 74,369 |
| BX JV I and II(4) | Outpatient medical | 6 | 20 | | 42,955 | | — |
| Lab JV | Lab | 1 | 49 | | 30,546 | | 31,406 |
| PMAK JV(2) | Outpatient medical | 59 | 12 | | 14,828 | | 21,711 |
First 8 of 14 rows. The CSV has all of them.
Table 17 after “The following table summarizes the Company’s intangible lease assets (dollars in thousands):”
Download CSV
| Intangible lease assets | September 30, 2026 | December 31, 2025 | |
| Gross intangible lease assets(1) | $1,478,559 | | $1,377,039 |
| Accumulated depreciation and amortization(2) | (560,859) | | (722,523) |
| Intangible assets | $917,700 | | $654,516 |
| Weighted average remaining amortization period in years | 4 | 5 | |
Table 18 after “The following table summarizes the Company’s intangible lease liabilities (dollars in thousands):”
Download CSV
| Intangible lease liabilities | September 30, 2026 | December 31, 2025 | |
| Gross intangible lease liabilities | $277,873 | | $316,197 |
| Accumulated depreciation and amortization | (131,185) | | (142,500) |
| Intangible liabilities | $146,688 | | $173,697 |
| Weighted average remaining amortization period in years | 9 | 9 | |
Table 19 after “At September 30, 2026 and December 31, 2025, goodwill was allocated to the Company’s segment assets as follows (in thousands):”
Download CSV
| Segment | September 30, 2026 | December 31, 2025 | |
| Outpatient medical | $64,680 | | $64,680 |
| Senior housing | 3,849 | | 3,849 |
| $68,529 | | $68,529 |
Table 20 after “The following table summarizes the Company’s senior unsecured note repayments during the three and nine months ended September 30, 2026 (dol”
Download CSV
| Repayment Date | Amount | Coupon Rate(1) | | Maturity Year | |
| July 15, 2026 | $650,000 | | 3.25% | | 2026 |
Table 21 after “The following table summarizes the Company’s senior unsecured note issuances for the year ended December 31, 2025 (dollars in thousands):”
Download CSV
| Issue Date | Amount | Coupon Rate(1) | | Maturity Year | |
| February 14, 2025 | $500,000 | | 5.38% | | 2035 |
| August 14, 2025 | 500,000 | | 4.75% | | 2033 |
Table 22 after “The following table summarizes the Company’s senior unsecured note repayments for the year ended December 31, 2025 (dollars in thousands):”
Download CSV
| Repayment Date | Amount | Coupon Rate(1) | | Maturity Year | |
| February 3, 2025 | $348,194 | | 3.40% | | 2025 |
| June 2, 2025 | 451,806 | | 4.00% | | 2025 |
Table 23 after “The following table summarizes the Company’s stated debt maturities and scheduled principal repayments at September 30, 2026 (dollars in tho”
Download CSV
| | | | | Senior UnsecuredNotes(3) | MortgageDebt(4) | | | | | | | | |
| Year | Bank Line of Credit(1) | Commercial Paper(1)(2) | | Term Loans | Amount | Interest Rate(5) | | Amount | Interest Rate(5) | Total | | | | |
| 2026 | $— | | $— | | $— | | $— | | —% | | $100,225 | 5.76% | | $100,225 |
| 2027 | — | | — | | 500,000 | | 850,000 | | 3.23% | | 842 | 4.57% | | 1,350,842 |
| 2028 | — | | — | | 400,000 | | 850,000 | | 3.53% | | 2,775 | 3.53% | | 1,252,775 |
| 2029 | — | | 1,489,500 | | 750,000 | | 650,000 | | 3.65% | | — | —% | | 2,889,500 |
| 2030 | — | | — | | — | | 750,000 | | 3.14% | | — | —% | | 750,000 |
| Thereafter | — | | — | | — | | 3,150,000 | | 5.08% | | — | —% | | 3,150,000 |
First 8 of 11 rows. The CSV has all of them.
Table 24 after “The following table summarizes the Company’s accumulated other comprehensive income (loss) (in thousands):”
Download CSV
| September 30, 2026 | December 31, 2025 | |
| Unrealized gains (losses) on derivatives, net | $29,664 | | $(8,110) |
| Supplemental Executive Retirement Plan minimum liability | (1,606) | | (1,827) |
| Total accumulated other comprehensive income (loss) | $28,058 | | $(9,937) |
Table 25 after “The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Numerator - Basic | | | | | | |
| Net income (loss) | $36,687 | | $(109,848) | | $299,584 | $(20,765) |
| Noncontrolling interests’ share in earnings | (19,424) | | (7,274) | | (35,870) | (21,856) |
| Net income (loss) attributable to Healthpeak Properties, Inc. | 17,263 | | (117,122) | | 263,714 | (42,621) |
| Less: Participating securities’ share in earnings | (145) | | (134) | | (444) | (714) |
| Net income (loss) applicable to common shares | $17,118 | | $(117,256) | | $263,270 | $(43,335) |
First 8 of 20 rows. The CSV has all of them.
Table 26 after “The following table summarizes financial information for the reportable segments for the three months ended September 30, 2026 (in thousands”
Download CSV
| Outpatient Medical | Lab | | Senior Housing | | Total | | |
| Total revenues | $314,752 | | $223,870 | | $268,300 | | | |
| Operating expenses(1) | (107,000) | | (75,058) | | | | | |
| Healthpeak’s share of unconsolidated joint venture NOI | 5,652 | | 5,865 | | | | | |
| Noncontrolling interests’ share of consolidated joint venture NOI | (20,700) | | — | | | | | |
| NOI - outpatient medical and lab | 192,704 | | 154,677 | | | | | |
| Adjustments to NOI(2) | (8,432) | | (13,809) | | | | | |
| Adjusted NOI - outpatient medical and lab | $184,272 | | $140,868 | | | | | $325,140 |
First 8 of 38 rows. The CSV has all of them.
Table 27 after “The following table summarizes the Company’s significant expense categories for the outpatient medical and lab reportable segments for the t”
Download CSV
| Outpatient Medical | Lab | |
| Compensation and property management | $15,887 | | $9,330 |
| Real estate taxes | 23,677 | | 22,472 |
| Repairs and maintenance | 19,521 | | 10,658 |
| Utilities | 21,074 | | 18,188 |
| Other segment items(1) | 26,841 | | 14,410 |
| Operating expenses | $107,000 | | $75,058 |
Table 28 after “The following table summarizes financial information for the reportable segments for the three months ended September 30, 2025 (in thousands”
Download CSV
| Outpatient Medical | Lab | | Senior Housing | | Total | | |
| Total revenues | $320,903 | | $213,325 | | $150,458 | | | |
| Operating expenses(1) | (110,431) | | (64,352) | | | | | |
| Healthpeak’s share of unconsolidated joint venture NOI | 4,440 | | 4,605 | | | | | |
| Noncontrolling interests’ share of consolidated joint venture NOI | (6,569) | | — | | | | | |
| NOI - outpatient medical and lab | 208,343 | | 153,578 | | | | | |
| Adjustments to NOI(2) | (10,300) | | (15,520) | | | | | |
| Adjusted NOI - outpatient medical and lab | $198,043 | | $138,058 | | | | | $336,101 |
First 8 of 39 rows. The CSV has all of them.
Table 29 after “The following table summarizes the Company’s significant expense categories for the outpatient medical and lab reportable segments for the t”
Download CSV
| Outpatient Medical | Lab | |
| Compensation and property management | $15,043 | | $8,484 |
| Real estate taxes | 25,068 | | 19,500 |
| Repairs and maintenance | 17,000 | | 8,966 |
| Utilities | 21,168 | | 14,855 |
| Other segment items(1) | 32,152 | | 12,547 |
| Operating expenses | $110,431 | | $64,352 |
Table 30 after “The following table summarizes financial information for the reportable segments for the nine months ended September 30, 2026 (in thousands)”
Download CSV
| Outpatient Medical | Lab | | Senior Housing | | Total | | |
| Total revenues | $943,640 | | $652,793 | | $685,101 | | | |
| Operating expenses(1) | (316,740) | | (211,461) | | | | | |
| Healthpeak’s share of unconsolidated joint venture NOI | 16,078 | | 18,113 | | | | | |
| Noncontrolling interests’ share of consolidated joint venture NOI | (34,840) | | (54) | | | | | |
| NOI - outpatient medical and lab | 608,138 | | 459,391 | | | | | |
| Adjustments to NOI(2) | (27,484) | | (34,890) | | | | | |
| Adjusted NOI - outpatient medical and lab | $580,654 | | $424,501 | | | | | $1,005,155 |
First 8 of 44 rows. The CSV has all of them.
Table 31 after “The following table summarizes the Company’s significant expense categories for the outpatient medical and lab reportable segments for the n”
Download CSV
| Outpatient Medical | Lab | |
| Compensation and property management | $47,115 | | $27,920 |
| Real estate taxes | 72,136 | | 66,097 |
| Repairs and maintenance | 56,553 | | 29,992 |
| Utilities | 58,260 | | 44,142 |
| Other segment items(1) | 82,676 | | 43,310 |
| Operating expenses | $316,740 | | $211,461 |
Table 32 after “The following table summarizes financial information for the reportable segments for the nine months ended September 30, 2025 (in thousands)”
Download CSV
| Outpatient Medical | Lab | | Senior Housing | | Total | | |
| Total revenues | $950,135 | | $640,123 | | $448,240 | | | |
| Operating expenses(1) | (315,136) | | (181,412) | | | | | |
| Healthpeak’s share of unconsolidated joint venture NOI | 13,193 | | 11,199 | | | | | |
| Noncontrolling interests’ share of consolidated joint venture NOI | (20,983) | | — | | | | | |
| NOI - outpatient medical and lab | 627,209 | | 469,910 | | | | | |
| Adjustments to NOI(2) | (32,959) | | (42,844) | | | | | |
| Adjusted NOI - outpatient medical and lab | $594,250 | | $427,066 | | | | | $1,021,316 |
First 8 of 39 rows. The CSV has all of them.
Table 33 after “The following table summarizes the Company’s significant expense categories for the outpatient medical and lab reportable segments for the n”
Download CSV
| Outpatient Medical | Lab | |
| Compensation and property management | $43,901 | | $25,071 |
| Real estate taxes | 73,455 | | 57,510 |
| Repairs and maintenance | 46,586 | | 24,526 |
| Utilities | 56,586 | | 35,965 |
| Other segment items(1) | 94,608 | | 38,340 |
| Operating expenses | $315,136 | | $181,412 |
Table 34 after “The following table summarizes the Company’s revenues by reportable segment (in thousands):”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| Segment | 2026 | 2025 | | 2026 | 2025 | |
| Outpatient medical | $314,752 | | $320,903 | | $943,640 | $950,135 |
| Lab | 223,870 | | 213,325 | | 652,793 | 640,123 |
| Senior housing | 268,300 | | 150,458 | | 685,101 | 448,240 |
| Total revenues for reportable segments | 806,922 | | 684,686 | | 2,281,534 | 2,038,498 |
| Total revenues for other non-reportable | 6,768 | | 5,658 | | 20,747 | 17,456 |
| Interest income and other | 7,202 | | 15,529 | | 43,142 | 47,156 |
First 8 of 9 rows. The CSV has all of them.
Table 35 after “The following table provides supplemental cash flow information (in thousands):”
Download CSV
| Nine Months Ended September 30, | | |
| 2026 | 2025 | |
| Supplemental cash flow information: | | | |
| Interest paid, net of capitalized interest | $273,084 | | $219,686 |
| Income taxes paid (refunded), net | 5,208 | | 2,089 |
| Capitalized interest | 57,715 | | 63,541 |
| Supplemental schedule of non-cash investing and financing activities: | | | |
| Accrued construction costs | $144,906 | | $164,460 |
First 8 of 14 rows. The CSV has all of them.
Table 36 after “The following table summarizes cash, cash equivalents, and restricted cash (in thousands):”
Download CSV
| Nine Months Ended September 30, | | |
| 2026 | 2025 | |
| Beginning of period: | | | |
| Cash and cash equivalents | $467,457 | | $119,818 |
| Restricted cash | 70,245 | | 64,487 |
| Cash, cash equivalents, and restricted cash | $537,702 | | $184,305 |
| End of period: | | | |
| Cash and cash equivalents | $514,310 | | $91,038 |
First 8 of 10 rows. The CSV has all of them.
Table 37 after “The classification of the related assets and the maximum loss exposure as a result of the Company’s involvement with VIEs at September 30, 2”
Download CSV
| VIE Type | Asset Type | Maximum LossExposure and Carrying Amount(1) |
| LLC Investment and Other Equity Investments | Other assets | $34,240 |
| Needham Land Parcel JV | Investments in unconsolidated joint ventures | 13,960 |
| Loans Receivable Investments | Loans receivable, net | 37,688 |
Table 38 after “Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):”
Download CSV
| September 30, 2026 | December 31, 2025 | |
| Assets | | | |
| Buildings and improvements | $9,337,618 | | $4,697,185 |
| Development costs and construction in progress | 306,933 | | 190,603 |
| Land and improvements | 1,097,335 | | 532,374 |
| Accumulated depreciation | (1,869,357) | | (930,916) |
| Net real estate | 8,872,529 | | 4,489,246 |
| Loans receivable, net | 181,285 | | 552,113 |
First 8 of 29 rows. The CSV has all of them.
Table 39 after “The table below summarizes the carrying amounts and fair values of the Company’s financial instruments either recorded or disclosed on a rec”
Download CSV
| September 30, 2026(3) | December 31, 2025(3) | | | | |
| Carrying Value | Fair Value | | Carrying Value | Fair Value | |
| Loans receivable, net(2) | $284,203 | | $290,947 | | $606,020 | $620,575 |
| Interest rate swap assets(2) | 29,908 | | 29,908 | | 5,626 | 5,626 |
| Bank line of credit and commercial paper(2) | 1,489,500 | | 1,489,500 | | 1,078,850 | 1,078,850 |
| Term loans(2) | 1,646,725 | | 1,646,725 | | 1,647,113 | 1,647,113 |
| Senior unsecured notes(1) | 6,142,101 | | 5,918,687 | | 6,772,722 | 6,813,448 |
| Mortgage debt(2) | 104,019 | | 103,526 | | 349,209 | 347,291 |
First 8 of 9 rows. The CSV has all of them.
Table 40 after “The following table summarizes the Company’s interest rate swap instruments (in thousands):”
Download CSV
| | | | | | Fair Value(2) | | | |
| Date Entered(1) | Maturity Date | Hedge Designation | Notional Amount | Pay Rate | Receive Rate | September 30, 2026 | | December 31, 2025 | |
| Interest rate swap assets: | | | | | | | | | |
| April 2022 | May 2026 | Cash flow | $51,100 | | 4.99 % | USD-SOFR w/ -5 Day Lookback + 2.50% | $— | | $193 |
| April 2022 | May 2026 | Cash flow | 91,000 | | 4.54 % | USD-SOFR w/ -5 Day Lookback + 2.05% | — | | 344 |
| August 2022 | February 2027 | Cash flow | 250,000 | | 2.60 % | 1 mo. USD-SOFR CME Term | 1,426 | | 2,109 |
| August 2022 | August 2027 | Cash flow | 250,000 | | 2.54 % | 1 mo. USD-SOFR CME Term | 4,000 | | 2,980 |
| May 2023(3) | May 2028 | Cash flow | 400,000 | | 3.59 % | USD-SOFR w/ -5 Day Lookback | 6,265 | | — |
First 8 of 14 rows. The CSV has all of them.
Table 41 after “The following table summarizes the Company’s accounts payable, accrued liabilities, and other liabilities (in thousands):”
Download CSV
| September 30, 2026 | December 31, 2025 | |
| Refundable entrance fees | $224,788 | | $221,147 |
| Accrued construction costs | 144,906 | | 144,524 |
| Accrued interest | 53,710 | | 89,202 |
| Other accounts payable and accrued liabilities | 325,606 | | 263,636 |
| Accounts payable, accrued liabilities, and other liabilities | $749,010 | | $718,509 |
Table 42 after “The following table summarizes the Company’s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in ”
Download CSV
| September 30, 2026 | December 31, 2025 | |
| Non-refundable entrance fees | $712,221 | | $669,528 |
| Other deferred revenue(1) | 326,945 | | 315,779 |
| Deferred revenue | $1,039,166 | | $985,307 |
Table 43 after “At September 30, 2026, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of inte”
Download CSV
| Segment | NOI by Reportable Segment(1) | Adjusted NOI by Reportable Segment(1) | |
| Outpatient medical | $192,704 | | $184,272 |
| Lab | 154,677 | | 140,868 |
| Senior housing | 53,158 | | 53,655 |
Table 44 after “The following table summarizes our common stock cash dividends declared in 2026:”
Download CSV
| Declaration Date | Record Date | Amount Per Share | Dividend Payment Date |
| January 4 | January 16 | $0.10167 | January 30 |
| January 4 | February 13 | 0.10167 | February 27 |
| January 4 | March 17 | 0.10167 | March 31 |
| April 6 | April 17 | 0.10167 | April 30 |
| April 6 | May 18 | 0.10167 | May 29 |
| April 6 | June 15 | 0.10167 | June 26 |
| July 9 | July 20 | 0.10167 | July 31 |
First 8 of 13 rows. The CSV has all of them.
| Three Months Ended September 30, | | | | |
| 2026 | 2025 | | Change | |
| Net income (loss) applicable to common shares | $17,118 | | $(117,256) | | $134,374 |
| Nareit FFO applicable to common shares | 296,789 | | 318,155 | | (21,366) |
| FFO as Adjusted applicable to common shares | 304,888 | | 318,750 | | (13,862) |
Table 46 after “The following table summarizes results for the nine months ended September 30, 2026 and 2025 (in thousands):”
Download CSV
| Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | Change | |
| Net income (loss) applicable to common shares | $263,270 | | $(43,335) | | $306,605 |
| Nareit FFO applicable to common shares | 912,759 | | 940,418 | | (27,659) |
| FFO as Adjusted applicable to common shares | 938,269 | | 965,087 | | (26,818) |
Table 47 after “The following table summarizes results at and for the three months ended September 30, 2026 and 2025 (dollars and square feet in thousands, ”
Download CSV
| Same-Store | Total Portfolio(1) | | | | | | | | |
| Three Months Ended September 30, | Three Months Ended September 30, | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | 2025 | | Change | | |
| Rental and related revenues | $299,537 | | $299,517 | | $20 | | $314,752 | | $320,903 | $(6,151) |
| Operating expenses | (101,295) | | (101,835) | | 540 | | (107,000) | | (110,431) | 3,431 |
| Healthpeak’s share of unconsolidated joint venture NOI | 5,145 | | 4,235 | | 910 | | 5,652 | | 4,440 | 1,212 |
| Noncontrolling interests’ share of consolidated joint venture NOI | (22,415) | | (25,280) | | 2,865 | | (20,700) | | (6,569) | (14,131) |
| NOI | 180,972 | | 176,637 | | 4,335 | | 192,704 | | 208,343 | (15,639) |
First 8 of 19 rows. The CSV has all of them.
Table 48 after “The following table summarizes results at and for the nine months ended September 30, 2026 and 2025 (dollars and square feet in thousands, e”
Download CSV
| Same-Store | Total Portfolio(1) | | | | | | | | | |
| Nine Months Ended September 30, | Nine Months Ended September 30, | | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | 2025 | | Change | | | |
| Rental and related revenues | $893,712 | | $881,574 | | $12,138 | | $943,640 | | | $950,135 | $(6,495) |
| Operating expenses | (297,351) | | (288,286) | | (9,065) | | (316,740) | | | (315,136) | (1,604) |
| Healthpeak’s share of unconsolidated joint venture NOI | 14,509 | | 12,797 | | 1,712 | | 16,078 | | | 13,193 | 2,885 |
| Noncontrolling interests’ share of consolidated joint venture NOI | (71,394) | | (77,148) | | 5,754 | | (34,840) | | | (20,983) | (13,857) |
| NOI | 539,476 | | 528,937 | | 10,539 | | 608,138 | | | 627,209 | (19,071) |
First 8 of 19 rows. The CSV has all of them.
Table 49 after “The following table summarizes results at and for the three months ended September 30, 2026 and 2025 (dollars and square feet in thousands, ”
Download CSV
| Same-Store | Total Portfolio(1) | | | | | | | | | | |
| Three Months Ended September 30, | Three Months Ended September 30, | | | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | | 2025 | | Change | | | |
| Rental and related revenues | $167,331 | | $173,271 | | $(5,940) | | | $223,870 | | $213,325 | | $10,545 |
| Operating expenses | (50,884) | | (49,382) | | (1,502) | | | (75,058) | | (64,352) | | (10,706) |
| Healthpeak’s share of unconsolidated joint venture NOI | 2,936 | | 2,942 | | (6) | | | 5,865 | | 4,605 | | 1,260 |
| NOI | 119,383 | | 126,831 | | (7,448) | | | 154,677 | | 153,578 | | 1,099 |
| Adjustments to NOI(2) | (5,792) | | (12,391) | | 6,599 | | | (13,809) | | (15,520) | | 1,711 |
First 8 of 18 rows. The CSV has all of them.
Table 50 after “The following table summarizes results at and for the nine months ended September 30, 2026 and 2025 (dollars and square feet in thousands, e”
Download CSV
| Same-Store | Total Portfolio(1) | | | | | | | | | | |
| Nine Months Ended September 30, | Nine Months Ended September 30, | | | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | | 2025 | | Change | | | |
| Rental and related revenues | $488,856 | | $520,199 | | $(31,343) | | | $652,793 | | $640,123 | | $12,670 |
| Operating expenses | (143,978) | | (139,745) | | (4,233) | | | (211,461) | | (181,412) | | (30,049) |
| Healthpeak’s share of unconsolidated joint venture NOI | 7,095 | | 6,907 | | 188 | | | 18,113 | | 11,199 | | 6,914 |
| Noncontrolling interests’ share of consolidated joint venture NOI | — | | — | | — | | | (54) | | — | | (54) |
| NOI | 351,973 | | 387,361 | | (35,388) | | | 459,391 | | 469,910 | | (10,519) |
First 8 of 19 rows. The CSV has all of them.
Table 51 after “The following table summarizes results at and for the three months ended September 30, 2026 and 2025 (dollars in thousands, except per unit ”
Download CSV
| Same-Store | Total Portfolio | | | | | | | | |
| Three Months Ended September 30, | Three Months Ended September 30, | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | 2025 | | Change | | |
| Resident fees and services | $165,203 | | $150,458 | | $14,745 | | $268,300 | | $150,458 | $117,842 |
| Operating expenses | (119,147) | | (113,870) | | (5,277) | | (193,419) | | (113,910) | (79,509) |
| Healthpeak’s share of unconsolidated joint venture NOI | — | | — | | — | | — | | 5,639 | (5,639) |
| Noncontrolling interests’ share of consolidated NOI(1) | (14,185) | | (11,269) | | (2,916) | | (21,723) | | — | (21,723) |
| NOI | 31,871 | | 25,319 | | 6,552 | | 53,158 | | 42,187 | 10,971 |
First 8 of 17 rows. The CSV has all of them.
Table 52 after “The following table summarizes results at and for the nine months ended September 30, 2026 and 2025 (dollars in thousands, except per unit d”
Download CSV
| Same-Store | Total Portfolio | | | | | | | | | |
| Nine Months Ended September 30, | Nine Months Ended September 30, | | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | 2025 | | Change | | | |
| Resident fees and services | $486,825 | | $448,240 | | $38,585 | | $685,101 | | | $448,240 | $236,861 |
| Operating expenses | (353,096) | | (335,505) | | (17,591) | | (496,803) | | | (335,618) | (161,185) |
| Healthpeak’s share of unconsolidated joint venture NOI | — | | — | | — | | 748 | | | 17,794 | (17,046) |
| Noncontrolling interests’ share of consolidated NOI(1) | (41,188) | | (34,723) | | (6,465) | | (34,611) | | | — | (34,611) |
| NOI | 92,541 | | 78,012 | | 14,529 | | 154,435 | | | 130,416 | 24,019 |
First 8 of 17 rows. The CSV has all of them.
Table 53 after “The following table summarizes the results of our other income and expense items for the three and nine months ended September 30, 2026 and ”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | | | | | |
| 2026 | 2025 | | Change | 2026 | 2025 | | Change | | |
| Interest income and other | $7,202 | | $15,529 | | $(8,327) | | $43,142 | | $47,156 | $(4,014) |
| Depreciation and amortization | 298,923 | | 262,317 | | 36,606 | | 872,047 | | 796,779 | 75,268 |
| Interest expense | 83,899 | | 76,784 | | 7,115 | | 263,471 | | 224,540 | 38,931 |
| General and administrative | 23,589 | | 19,907 | | 3,682 | | 70,697 | | 66,789 | 3,908 |
| Transaction costs | 9,738 | | 2,420 | | 7,318 | | 43,059 | | 18,169 | 24,890 |
| Impairments and loan loss reserves (recoveries), net | (210) | | (54) | | (156) | | (3,964) | | (117) | (3,847) |
First 8 of 14 rows. The CSV has all of them.
Table 54 after “The following table sets forth changes in cash flows (in thousands):”
Download CSV
| Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | Change | |
| Net cash provided by (used in) operating activities | $976,440 | | $957,875 | | $18,565 |
| Net cash provided by (used in) investing activities | (2,578,978) | | (629,053) | | (1,949,925) |
| Net cash provided by (used in) financing activities | 1,670,658 | | (353,395) | | 2,024,053 |
Table 55 after “The following is a reconciliation from net income (loss) applicable to common shares, the most directly comparable financial measure calcula”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Net income (loss) applicable to common shares | $17,118 | | $(117,256) | | $263,270 | $(43,335) |
| Real estate related depreciation and amortization | 298,923 | | 262,317 | | 872,047 | 796,779 |
| Healthpeak’s share of real estate related depreciation and amortization from unconsolidated joint ventures | 7,564 | | 12,574 | | 22,420 | 37,304 |
| Noncontrolling interests’ share of real estate related depreciation and amortization | (26,816) | | (3,807) | | (46,939) | (12,686) |
| Loss (gain) on sales of depreciable real estate, net | — | | (11,500) | | (60,657) | (13,136) |
| Healthpeak’s share of loss (gain) on sales of depreciable real estate, net, from unconsolidated joint ventures | — | | — | | 1,793 | — |
First 8 of 34 rows. The CSV has all of them.
Table 56 after “For a reconciliation of Adjusted NOI for our outpatient medical and lab reportable segments to net income (loss) before income taxes and equ”
Download CSV
| Three Months Ended September 30, | Nine Months Ended September 30, | | | | |
| 2026 | 2025 | | 2026 | 2025 | |
| Net income (loss) | $(5,608) | | $1,412 | | $37,124 | $(5,987) |
| Depreciation and amortization | 78,682 | | 30,885 | | 186,553 | 94,875 |
| General and administrative | 1,527 | | 2,267 | | 5,819 | 7,781 |
| General and administrative - related party management fee | 3,779 | | — | | 6,579 | — |
| Interest expense | 486 | | 950 | | 1,187 | 2,847 |
| Transaction costs | 3,400 | | — | | 26,188 | — |
First 8 of 19 rows. The CSV has all of them.
| 3.1 | Articles of Amendment and Restatement of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.) effective February 10, 2023 (incorporated herein by reference to Exhibit 3.1 to Healthpeak’s Current Report on Form 8-K12B filed February 10, 2023). |
| 3.2 | Articles of Amendment of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.) effective February 10, 2023 (incorporated herein by reference to Exhibit 3.2 to Healthpeak’s Current Report on Form 8-K12B filed February 10, 2023). |
| 3.3 | Articles of Amendment of Healthpeak Properties, Inc., effective February 29, 2024 (incorporated herein by reference to Exhibit 3.1 to Healthpeak’s Current Report on Form 8-K filed March 1, 2024). |
| 3.4 | Amended and Restated Bylaws of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.), dated February 10, 2023 (incorporated herein by reference to Exhibit 3.4 to Healthpeak’s Current Report on Form 8-K12B filed February 10, 2023). |
| 3.5 | Amendment to the Bylaws of Healthpeak Properties, Inc., effective March 1, 2024 (incorporated herein by reference to Exhibit 3.2 to Healthpeak’s Current Report on Form 8-K filed March 1, 2024). |
| 10.1*† | Amendment No. 6 to Term Loan Agreement, dated October 28, 2026, by and among Healthpeak OP, LLC, Healthpeak Properties, Inc. DOC DR Holdco, LLC, DOC DR, LLC, the lenders listed therein, and Bank of America, N.A., as administrative agent. |
| 22.1 | List of Issuers of Guaranteed Securities (incorporated herein by reference to Exhibit 22.1 to Healthpeak's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed on August 5, 2026). |
| 31.1* | Certification by Scott M. Brinker, Healthpeak’s Principal Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(a). |
First 8 of 18 rows. The CSV has all of them.